| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.23B | 1.04B | 909.77M | 691.06M | 695.67M | 731.62M |
| Gross Profit | 697.80M | 653.18M | 616.19M | 606.68M | 653.15M | 573.44M |
| EBITDA | 201.32M | 277.25M | 212.42M | 254.05M | 270.18M | 138.12M |
| Net Income | 147.07M | 195.46M | 144.68M | 166.07M | 175.89M | 83.65M |
Balance Sheet | ||||||
| Total Assets | 26.73B | 18.03B | 17.36B | 16.99B | 16.81B | 14.93B |
| Cash, Cash Equivalents and Short-Term Investments | 1.09B | 1.92B | 1.72B | 2.11B | 4.26B | 1.98B |
| Total Debt | 1.16B | 538.63M | 736.98M | 1.14B | 485.16M | 496.31M |
| Total Liabilities | 22.90B | 15.36B | 15.06B | 14.85B | 14.60B | 12.80B |
| Stockholders Equity | 3.83B | 2.68B | 2.30B | 2.14B | 2.21B | 2.13B |
Cash Flow | ||||||
| Free Cash Flow | 222.85M | 115.78M | 126.92M | 559.21M | 122.14M | 53.97M |
| Operating Cash Flow | 256.43M | 129.43M | 148.55M | 574.04M | 142.66M | 82.24M |
| Investing Cash Flow | -1.03B | -298.04M | -55.40M | -2.04B | -660.00M | -1.27B |
| Financing Cash Flow | 586.31M | 459.30M | 132.21M | 167.64M | 1.76B | 1.40B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $4.07B | 18.53 | 6.25% | 3.05% | 11.05% | -10.78% | |
78 Outperform | $4.13B | 13.19 | 9.23% | 3.02% | 5.63% | 65.11% | |
76 Outperform | $4.64B | 15.40 | 9.44% | ― | 5.19% | 3454.95% | |
75 Outperform | $3.96B | 10.58 | 11.71% | 3.52% | 9.60% | 20.38% | |
72 Outperform | $3.82B | 19.42 | 5.52% | 2.47% | 20.26% | -35.00% | |
70 Outperform | $5.09B | 49.67 | 2.22% | 2.72% | -1.18% | -89.13% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
Renasant Corporation reported fourth-quarter 2025 net income of $78.9 million, equivalent to diluted EPS of $0.83 and adjusted diluted EPS of $0.91, supported by a net interest margin of 3.89% and an adjusted net interest margin of 3.62%. During the quarter, loans inched up $21.5 million on an annualized basis despite the sale of about $117.3 million of non-core loans acquired in the merger with The First Bancshares, while deposits rose $48.5 million, with noninterest-bearing balances declining to 23.5% of total deposits as the cost of total deposits fell 17 basis points to 1.97%. Credit quality metrics remained relatively stable, with the allowance for credit losses on loans at 1.54% of total loans, nonperforming loans at 0.92% and criticized loans down to 2.94%, as the company also redeemed $60 million of subordinated notes obtained in the First Bancshares merger and repurchased $13.2 million of its common stock, decisions that collectively signal active balance-sheet optimization and capital management amid a competitive and risk-conscious banking environment.
The most recent analyst rating on (RNST) stock is a Buy with a $46.00 price target. To see the full list of analyst forecasts on Renasant stock, see the RNST Stock Forecast page.
On January 27, 2026, Renasant Corporation reported fourth-quarter 2025 net income of $78.9 million, or $0.83 in diluted earnings per share, including $10.6 million in merger and conversion-related expenses tied to its integration of The First Bancshares, while adjusted diluted EPS rose to $0.91, reflecting improved profitability and cost control. Net interest income grew to $232.4 million with a higher net interest margin and a lower cost of deposits, noninterest income increased partly due to the exit of certain low-income housing tax credit partnerships, and noninterest expenses declined as merger-related costs eased and branch consolidations generated gains. The balance sheet showed modest loan growth despite the sale of $117.3 million of non-core acquired loans, higher securities holdings, and a linked-quarter increase in total deposits, while book value and tangible book value per share improved and the company continued to return capital through $13.2 million of share repurchases and the redemption of $60 million in subordinated notes. Credit quality metrics were generally stable with a small uptick in nonperforming loans, higher provision for unfunded commitments, and net charge-offs influenced by the sale of acquired loans, leaving allowance coverage robust as management emphasized steady integration progress, balance sheet growth on both sides, and what it sees as solid positioning for further growth in 2026.
The most recent analyst rating on (RNST) stock is a Hold with a $39.00 price target. To see the full list of analyst forecasts on Renasant stock, see the RNST Stock Forecast page.
On November 10, 2025, Dr. Richard Heyer informed Renasant Corporation that he will not seek re-election as a director at the company’s 2026 Annual Meeting of Shareholders, scheduled for April 28, 2026. Dr. Heyer will also retire from the board of Renasant Bank, a subsidiary of the company. His decision was not due to any disagreements with the company’s operations, policies, or practices.
The most recent analyst rating on (RNST) stock is a Hold with a $38.00 price target. To see the full list of analyst forecasts on Renasant stock, see the RNST Stock Forecast page.
In the third quarter of 2025, Renasant Corporation reported a net income of $59.8 million and a diluted EPS of $0.63. The company experienced a 9.9% annualized increase in loans while deposits decreased due to public fund seasonality. The merger with The First Bancshares, Inc. presents opportunities and risks, including integration challenges and regulatory scrutiny, which could impact Renasant’s financial performance and growth strategy.
The most recent analyst rating on (RNST) stock is a Buy with a $41.00 price target. To see the full list of analyst forecasts on Renasant stock, see the RNST Stock Forecast page.